These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11257620)

  • 1. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D; Sellheyer K
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
    Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
    Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
    Mateoiu C; Pirici A; Bogdan F
    Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms.
    Kirchmann TT; Prieto VG; Smoller BR
    J Cutan Pathol; 1995 Oct; 22(5):422-6. PubMed ID: 8594074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens.
    Lum CA; Binder SW
    J Cutan Pathol; 2004 Sep; 31(8):550-4. PubMed ID: 15268710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors.
    Wick MR; Cooper PH; Swanson PE; Kaye VN; Sun TT
    Arch Dermatol; 1990 Feb; 126(2):189-94. PubMed ID: 1689137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
    Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
    J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.
    Vollmer RT; Humphrey PA; Swanson PE; Wick MR; Hudson ML
    Cancer; 1998 Feb; 82(4):715-23. PubMed ID: 9477105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected immunohistochemical prognostic factors in endometrial cancer.
    Markova I; Duskova M; Lubusky M; Kudela M; Zapletalová J; Procházka M; Pilka R
    Int J Gynecol Cancer; 2010 May; 20(4):576-82. PubMed ID: 20686376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB; Papadimitriou JC; Drachenberg CB
    Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
    Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm.
    LeBoit PE; Sexton M
    J Am Acad Dermatol; 1993 Oct; 29(4):609-18. PubMed ID: 7691906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.